Topic: Michael Ezekowitz
An experimental blood thinner developed by Merck and Portola Pharmaceuticals was found to be safe and effective in a mid-stage study presented Monday, with a lower incidence of serious bleeding than current drugs.The Phase II randomized trial compared the effects of betrixaban, ...
An experimental blood thinner developed by Merck and Portola Pharmaceuticals was found to be safe and effective in a mid-stage study presented Monday, with a lower incidence of serious bleeding than current drugs.The Phase II randomized trial compared the effects of betrixaban, ...
